Nurix therapeutics to participate and present at upcoming investor conferences

San francisco, march 09, 2021 (globe newswire) -- nurix therapeutics, inc. (nasdaq: nrix), a biopharmaceutical company developing targeted protein modulation drugs, today announced that arthur sands, m.d., ph.d., nurix's chief executive officer, will participate and present at the following conferences in march:
NRIX Ratings Summary
NRIX Quant Ranking